(Q40621328)

English

Phase I trial of twice-weekly intravenous interleukin 12 in patients with metastatic renal cell cancer or malignant melanoma: ability to maintain IFN-gamma induction is associated with clinical response.

scientific article published on May 2000

Statements

Phase I trial of twice-weekly intravenous interleukin 12 in patients with metastatic renal cell cancer or malignant melanoma: ability to maintain IFN-gamma induction is associated with clinical response. (English)
1 May 2000
1678-1692

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit